What About the Mozarts of Science?

A decade ago, Bernadine Healy, then director of the National Institutes of Health, spoke of the "need to discover the new medical Mozarts among the many Salieris in biomedicine."1 For Healy, the popular play and movie Amadeus, which depicted the rivalry between Antonio Salieri and Wolfgang Mozart, makes an important statement about talent. Salieri, Healy recalled, was talented in a "workmanlike sort of way. He could compose and get the job done with competence. By contrast, Mozart was a mercuri

Written byWalter Brown
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Salieri, Healy recalled, was talented in a "workmanlike sort of way. He could compose and get the job done with competence. By contrast, Mozart was a mercurial, brilliant, difficult genius. The music he composed was not merely competent; it was sublime." The contrast between Mozart and Salieri raised a question for Healy about policy: "Can science and medicine flourish ... if we cultivate only the Salieris?" Her answer, of course, was no: "The talent base we need requires more Mozarts. Energetic, talented and irreverent youth must be encouraged .... The cost of finding, educating, and sending the medical Mozarts to the frontier is not cheap. But the cost of the only alternatives--ignorance and scientific stagnation--is incalculably higher."

Healy's question--and her answer--remain compelling. Who would not welcome the scientific equivalent of The Magic Flute? Unfortunately, no one has hit upon a way to find, cultivate, and sustain the Mozarts. Despite the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies